Fig. 7.
Fig. 7. Apoptosis of CD57+CD8+ T cells. / (A) CD8+CD57+ T cells, CD8+CD57− T cells, and CD8−CD57− lymphocytes were sorted by flow cytometry followed by PHA stimulation (5 μg/mL). Cells were stained for propidium iodide and analyzed 48 hours following stimulation. (B) PBMCs were stimulated for 12 hours using PHA (5 μg/mL) followed by addition of biotinylated substrate for caspase 3 (Z-VK [Biotin] D(OMe)-FMK, 43 μg/mL) for an additional 12 hours. PBMCs then were stained with anti–CD57 FITC, anti–CD69 APC, anti–CD8 PerCP, and strepavidin PE. Plots shown are gated on live CD8+CD69+ then discriminated based on CD57 expression. This experiment was performed on 3 individuals, and the data trends were identical. Percentages indicate fraction positive for propidium iodide or activated caspase inhibitor.

Apoptosis of CD57+CD8+ T cells.

(A) CD8+CD57+ T cells, CD8+CD57 T cells, and CD8CD57 lymphocytes were sorted by flow cytometry followed by PHA stimulation (5 μg/mL). Cells were stained for propidium iodide and analyzed 48 hours following stimulation. (B) PBMCs were stimulated for 12 hours using PHA (5 μg/mL) followed by addition of biotinylated substrate for caspase 3 (Z-VK [Biotin] D(OMe)-FMK, 43 μg/mL) for an additional 12 hours. PBMCs then were stained with anti–CD57 FITC, anti–CD69 APC, anti–CD8 PerCP, and strepavidin PE. Plots shown are gated on live CD8+CD69+ then discriminated based on CD57 expression. This experiment was performed on 3 individuals, and the data trends were identical. Percentages indicate fraction positive for propidium iodide or activated caspase inhibitor.

Close Modal

or Create an Account

Close Modal
Close Modal